OSAM
ORMP icon

O'Shaughnessy Asset Management’s Oramed Pharmaceuticals ORMP Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$396K Buy
+116,363
New +$395K ﹤0.01% 1638
2021
Q1 		– Sell
-141
Closed -$1K – 2435
2020
Q4 		$1K Buy
+141
New +$459 ﹤0.01% 1977
2020
Q3 		– Sell
-41
Closed – – 1962
2020
Q2 		$0 Buy
+41
New +$138 ﹤0.01% 1847

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

O'Shaughnessy Asset Management's ORMP Position: Q1 2026 in Review

O'Shaughnessy Asset Management opened a new position in Oramed Pharmaceuticals (ORMP) in Q1 2026: 116,363 shares worth $396K. The stake represents ﹤0.01% of the portfolio and ranks #1638 among its holdings. This is a return to the name: O'Shaughnessy Asset Management previously reported a position in ORMP as recently as Q4 2020.

O'Shaughnessy Asset Management first reported a position in ORMP in Q2 2020 and has held it in 3 quarters since. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • O'Shaughnessy Asset Management held 116,363 shares of Oramed Pharmaceuticals worth $396K as of Q1 2026.
  • Oramed Pharmaceuticals was a new O'Shaughnessy Asset Management position in Q1 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q1 2026, its #1638 holding.
  • O'Shaughnessy Asset Management first reported a position in Oramed Pharmaceuticals in Q2 2020 and has held it in 3 quarters since.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.